Inhibiting the enzyme glyoxalase 1 (Glo-1), which was originally identified as a metabolic housekeeping enzyme but also affects anxiety, relieved symptoms of depression more rapidly than Prozac (fluoxetine, Eli Lilly and Co.) in several different animal models.